Reneo Pharmaceuticals
RPHM
#9376
Rank
A$0.10 B
Marketcap
$30.44
Share price
952.02%
Change (1 day)
19.69%
Change (1 year)

Earnings for Reneo Pharmaceuticals (RPHM)

Earnings in 2024 (TTM): -A$93.39 Million

According to Reneo Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$0.14 Billion a decrease over its 2022 earnings that were of -A$90.08 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Reneo Pharmaceuticals from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$93.39 Million-32.78%
2023 -A$0.14 Billion54.24%
2022 -A$90.08 Million35.24%
2021 -A$66.61 Million103.66%
2020 -A$32.71 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.24 Billion 131.14%๐Ÿ‡บ๐Ÿ‡ธ USA